Gene Therapy Working Group

The SECB's Gene Therapy Working Group is responsible for evaluating experimental gene therapy.

Members of the Gene Therapy Working Group

Chair

  • Pascal Meylan, Prof. MD, Institut de Microbiologie de l'Université de Lausanne

Members (external experts)

  • Carlo V. Catapano, MD, PhD, Oncology Institute of Southern Switzerland, Bellinzona
  • Cornel Fraefel, Prof. PhD, Virologisches Institut Universität Zürich
  • Hussein Naim, PhD, Life Sciences and Vaccines Consultant, Bern
  • Jean-Claude Piffaretti, Prof. PhD, Interlifescience, Massagno
  • Janine Reichenbach, Prof. MD, Kinderspital Universität Zürich
  • Pedro Romero, Prof. MD, Ludwig Institute for Cancer Research, Lausanne
  • Sandro Rusconi, Prof. PhD, Repubblica e Cantone Ticino, Divisione della Cultura e degli Studi Universitari, Bellinzona

Executive Office

  • Isabel Hunger-Glaser, PhD, Executive Manager SECB, Bern

To the top
Last edition: 09.04.2019

Contact

Swiss Expert Committee for Biosafety (SECB)
Tel.: +41 (0)58 463 03 55
Tel.: +41 (0)58 463 23 12
Fax: +41 (0)58 464 79 78
info(at)efbs.admin.ch

Postal address

Postal address
Executive Office SECB
c/o Federal Office for the Environment
CH-3003 Bern

Map

Worblentalstrasse 68
3063 Ittigen

Timetable for public transport
Enter "Papiermühle" as destination station


Further information